Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN29385951) titled 'Using health information and blood tests (metabolites) to personalise the treatment of high blood pressure' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Proof-of-concept pragmatic adaptive open-label strategy trial embedded in routine clinical practice with stratified individual patient randomization (Treatment)
Primary Sponsor: University of Birmingham
Condition:
Hypertension
Circulatory System
Intervention:
The trial is organised into two phases. In the first phase, participants will be randomised to usual standard of care (group A) for treatment selection, or initial pharmacometabolomic app...